Net Loss per Share (Tables)

3 Months Ended

Mar. 31, 2023

Earnings Per Share [Abstract]

Schedule of Weighted-Average Common Shares Outstanding

The following securities are the weighted-average common shares outstanding used to calculate basic and diluted net loss per common share:

	As of March 31,
	2023		2022
Common stock		8,166,385		5,334,712
2022 pre-funded warrants		1,280,965		-
Total		9,447,350		5,334,712

Schedule of Potentially Dilutive Securities Outstanding Excluded from Computations of Diluted Weighted-Average Shares Outstanding

The following potentially dilutive securities outstanding have been excluded from the computations of diluted weighted-average shares outstanding for the periods presented because such securities have an antidilutive impact due to losses reported (in common stock equivalent shares):

	As of March 31,
	2023		2022
Warrants issued to 2010/2012 convertible note    holders to purchase common stock		6,804		6,804
Options to purchase common stock		926,325		516,445
Outstanding restricted stock units		9,534		19,233
Warrants issued to underwriter to purchase common stock		1,100		1,100
2018 PIPE warrants		34,241		34,241
2022 common warrants		4,000,000		4,000,000
Total		4,978,004		4,577,823